The history of the development of a new scientific or medical technology is a story of science in the making. In this paper we attempt to trace the development of the anti-hCG vaccine over the past 20 years, using controversy as a methodological entry point into the history.
In recent years there has been a growing concern in many countries, including India, that public health and family planning programs have placed insufficient emphasis on the quality of their services (Ickis 1992; Khan et al. 1994; Mensch 1993; Miller et al. 1991).
Sterilization for men and women is the most commonly used contraceptive method both in India at large and in Uttar Pradesh.
Sterilization is the most popular method of contraception in India. The 1992-93 National Family Health Survey found that of the 36.2 percent of eligible couples using any modern method, most (30.7 percent) had been sterilized and only 5.5 percent were using temporary methods (IIPS 1995).
The notion of quality in the public health system is becoming increasingly an issue for policymakers and planners in India. The Eighth Five-Year Plan identified the poor quality of family welfare services as one of the factors
The Shodhini experience has been able to draw upon a range of disciplines in an attempt to develop a woman-centered health care alternative.
The women's health movement in India today is fast gaining momentum, although there continues to be a vast gap between ground realities and women's aspirations. Women's groups are extremely active and are working towards the betterment of health care services nationwide.
The International Conference on Population and Development (ICPD) held in Cairo in 1994 reiterated the need for appropriate health care services that will enable women to go safely through pregnancy and childbirth and produce a healthy infant.
Viewed in retrospect, the development of hormonal methods of fertility control could be broadly divided into three main phases: (i) development of the oral contraceptive 'Pill based on synthetic ovarian steroid hormones; (ii) the demonstration that continuous oral administration of progestins in